Comparing Adalimumab vs Vedolizumab
| Adalimumab | Vedolizumab |
|
|---|
| Adalimumab | Vedolizumab |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Adalimumab is a TNF-alfa inhibitor that may be used to treat a wide range of different inflammatory conditions, such as rheumatoid Arthritis, psoriasis, ankylosing spondylitis, Crohn's disease, and... View more |
Prescription only
Prescribed for Ulcerative Colitis, Crohn's Disease - Maintenance, Crohn's Disease. Vedolizumab may also be used for purposes not listed in this medication guide. |
Related suggestions Ulcerative Colitis
Crohn's Disease
Crohn's Disease, Maintenance
|
|||||||
| More about Adalimumab | More about Vedolizumab | ||||||||
| Ratings & Reviews | |||||||||
|
Adalimumab has an average rating of 6.4 out of 10 from a total of 746 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 29% reported a negative effect. |
Vedolizumab has an average rating of 6.3 out of 10 from a total of 192 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 27% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Adalimumab side effects |
View all Vedolizumab side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Adalimumab prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Humira, Hyrimoz, Idacio, Simlandi, Yuflyma, Yusimry View more | Entyvio, Entyvio Pen | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
480 hours |
600 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 557 drugs are known to interact with Adalimumab:
|
A total of 171 drugs are known to interact with Vedolizumab:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
May 20, 2014 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
|
|||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.